Digestive System Adenocarcinoma — Trials

Digestive System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

5,072 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,374
Recruiting: 799
Ph III recruiting: 82
Growth YoY: +12.1%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (619)

clinicaltrialsPublishedShowing 301–350 of 1,007 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07595874	Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3(NEST3)	recruiting	Phase 2	100	City of Hope Medical CenterOTHER	1	Jul 1, 2026	clinicaltrials
NCT07679061	First-Line Nivolumab Plus Ipilimumab in Unresectable Hepatocellular Carcinoma (J-PROMISE)	recruiting	—	200	Bristol-Myers SquibbINDUSTRY	1	Jul 1, 2026